Prediction of Response to Antipsychotic Drugs in Schizophrenia Patients within the Early Phase of Treatment

Yildiz, MÜMİN; YAZICI, MÜMİN; YAGCIOGLU, A.; KARAHAN, SEVİLAY; SEVIK, Ali; GURSES, Nadide

doi:10.5455/bcp.20151128021707

Prediction of Response to Antipsychotic Drugs in Schizophrenia Patients within the Early Phase of Treatment

Yildiz M. K., YAZICI M. K., YAGCIOGLU A. E. A., KARAHAN S., SEVIK A. E., GURSES N.

KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY, vol.25, no.4, pp.390-398, 2015 (SCI-Expanded, Scopus, TRDizin)

Publication Type: Article / Article
Volume: 25 Issue: 4
Publication Date: 2015
Doi Number: 10.5455/bcp.20151128021707
Journal Name: KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY
Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, TR DİZİN (ULAKBİM)
Page Numbers: pp.390-398
Hacettepe University Affiliated: Yes

Abstract

Objective: Currently, schizophrenia guidelines recommend waiting for 3 to 6 weeks before considering a patient as non-responder. However, recent studies indicate that the response to antipsychotic medications starts within the first two weeks of treatment. The aim of this study is to determine the predictive value of early improvement at 2 or 4 weeks for non-response at 6 weeks.